clinical trial · NCT00568997
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
Bausch Health Americas, Inc.·—·active not recruiting·n = 8,000
Atopic DermatitisPimecrolimus
brief summary
This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.
started
Jun 27, 2005
primary completion
Dec 1, 2027
completion
Jun 1, 2028
last updated
Sep 16, 2025
detailed description
Registry study to examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.
official title
A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol